Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis.
Nissen MJ, Ciurea A, Bernhard J, Tamborrini G, Mueller R, Weiss B, Toniolo M, Exer P, Gabay C, Finckh A; physicians of the Swiss Clinical Quality Management Cohort. Nissen MJ, et al. Among authors: bernhard j. Arthritis Rheumatol. 2016 Sep;68(9):2141-50. doi: 10.1002/art.39691. Arthritis Rheumatol. 2016. PMID: 27015429 Free article.
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Among authors: bernhard j. Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140. Arthritis Rheum. 2013. PMID: 23983141 Free article.
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Ciurea A, Weber U, Stekhoven D, Scherer A, Tamborrini G, Bernhard J, Toniolo M, Villiger PM, Zufferey P, Kissling RO, Michel BA, Exer P; Rheumatologists of Swiss Clinical Quality Management. Ciurea A, et al. Among authors: bernhard j. J Rheumatol. 2015 Jan;42(1):101-5. doi: 10.3899/jrheum.140229. Epub 2014 Nov 1. J Rheumatol. 2015. PMID: 25362654
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
Ciurea A, Scherer A, Weber U, Exer P, Bernhard J, Tamborrini G, Riek M, Müller RB, Weiss B, Nissen MJ, Kissling R, Michel BA, Finckh A; Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Among authors: bernhard j. Ann Rheum Dis. 2016 Mar;75(3):532-9. doi: 10.1136/annrheumdis-2013-205133. Epub 2015 Feb 9. Ann Rheum Dis. 2016. PMID: 25667205
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
Ciurea A, Exer P, Weber U, Tamborrini G, Steininger B, Kissling RO, Bernhard J, Scherer A; Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Among authors: bernhard j. Arthritis Res Ther. 2016 Mar 22;18:71. doi: 10.1186/s13075-016-0969-2. Arthritis Res Ther. 2016. PMID: 27000865 Free PMC article.
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Micheroli R, Hebeisen M, Wildi LM, Exer P, Tamborrini G, Bernhard J, Möller B, Zufferey P, Nissen MJ, Scherer A, Ciurea A; Rheumatologists of the Swiss Clinical Quality Management Program. Micheroli R, et al. Among authors: bernhard j. Arthritis Res Ther. 2017 Jul 19;19(1):164. doi: 10.1186/s13075-017-1372-3. Arthritis Res Ther. 2017. PMID: 28724442 Free PMC article.
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.
Hebeisen M, Neuenschwander R, Scherer A, Exer P, Weber U, Tamborrini G, Micheroli R, Wildi LM, Zufferey P, Nissen MJ, Villiger PM, Bernhard J, Finckh A, van der Horst-Bruinsma IE, Sieper J, Landewé R, van der Heijde D, Ciurea A; rheumatologists of the Swiss Clinical Quality Management Program. Hebeisen M, et al. Among authors: bernhard j. J Rheumatol. 2018 Apr;45(4):506-512. doi: 10.3899/jrheum.170166. Epub 2018 Feb 15. J Rheumatol. 2018. PMID: 29449504
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landewé RBM, van der Heijde D, Ciurea A; Rheumatologists of the Swiss Clinical Quality Management Program. Molnar C, et al. Among authors: bernhard j. Ann Rheum Dis. 2018 Jan;77(1):63-69. doi: 10.1136/annrheumdis-2017-211544. Epub 2017 Sep 22. Ann Rheum Dis. 2018. PMID: 28939631 Free PMC article.
Age at symptom onset in ankylosing spondylitis: is there a gender difference?
Ciurea A, Scherer A, Weber U, Neuenschwander R, Tamborrini G, Exer P, Bernhard J, Villiger PM, Kissling R, Michel BA, Stekhoven D; rheumatologists of the Swiss Clinical Quality Management Program for axial spondyloarthritis. Ciurea A, et al. Among authors: bernhard j. Ann Rheum Dis. 2014 Oct;73(10):1908-10. doi: 10.1136/annrheumdis-2014-205613. Epub 2014 Aug 7. Ann Rheum Dis. 2014. PMID: 25104774 No abstract available.
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.
Pagani O, Klingbiel D, Ruhstaller T, Nolè F, Eppenberger S, Oehlschlegel C, Bernhard J, Brauchli P, Hess D, Mamot C, Munzone E, Pestalozzi B, Rabaglio M, Aebi S, Ribi K, Rochlitz C, Rothgiesser K, Thürlimann B, von Moos R, Zaman K, Goldhirsch A; Swiss Group for Clinical Cancer Research (SAKK). Pagani O, et al. Among authors: bernhard j. Ann Oncol. 2017 Feb 1;28(2):305-312. doi: 10.1093/annonc/mdw622. Ann Oncol. 2017. PMID: 27998961 Free article. Clinical Trial.
646 results